CSIMarket



Atyr Pharma Inc   (LIFE)
Other Ticker:  
 
 

LIFE's Operating Income Growth by Quarter and Year

Atyr Pharma Inc 's Operating Income results by quarter and year




LIFE Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -8.64 -4.94 -5.96
III Quarter September - -7.73 -6.51 -5.50
II Quarter June - -10.45 -6.32 -5.64
I Quarter March -12.38 -7.20 1.86 -5.88
FY   -12.38 -34.02 -15.91 -22.98



LIFE Operating Income first quarter 2022 Y/Y Growth Comment
Atyr Pharma Inc in the first quarter 2022 recorded Operating Loss of $ -12.38 millions.

According to the results reported in the first quarter 2022, Atyr Pharma Inc achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Atyr Pharma Inc ' s Operating Income no change of % ranks overall at the positon no. in the first quarter 2022.

Explain Operating Income growth


LIFE Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Atyr Pharma Inc 's first quarter 2022 Operating Income $ -12.38 millions LIFE's Income Statement
Atyr Pharma Inc 's first quarter 2021 Operating Income $ -7.20 millions Quarterly LIFE's Income Statement
New: More LIFE's historic Operating Income Growth >>


LIFE Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Atyr Pharma Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LIFE's I. Quarter Q/Q Operating Income Comment
Current results of -12.38 millions by Atyr Pharma Inc appear even more unfavourable considering the -8.64 millions Operating Loss in the forth quarter.

Within Biotechnology & Pharmaceuticals industry Atyr Pharma Inc achieved highest sequential Operating Income growth. While Atyr Pharma Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LIFE's I. Quarter Q/Q Operating Income Comment
Current Operating Loss of -12.38 millions by Atyr Pharma Inc look even more unfavourable compare to the -8.64 millions Operating Loss in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Atyr Pharma Inc achieved highest sequential Operating Income growth. While Atyr Pharma Inc 's Operating Income growth quarter on quarter, overall rank is .


Atyr Pharma Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ -39.19 $ -34.02 $ -30.32 $ -29.10 $ -24.97
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Atyr Pharma Inc ' has realized cumulative trailing twelve months Operating Loss of $ -39 millions in the Mar 31 2022 period.
The situation is worsening as the cumulative Operating Loss is getting bigger from $ -34.02 millions in TTM ending quarter Dec 31 2021 and $ -8.64 millions for the twelve months ending in the quarter Mar 31 2021.

Atyr Pharma Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Atyr Pharma Inc ' has realized cumulative trailing twelve months Operating Loss of $ -39 millions in the Mar 31 2022 period.
The results are detiriorating as the cumulative Operating Loss is getting bigger from $ -34.02 millions for the period from Dec 31 2021 to Mar 31 2021 and $ -8.64 millions for the twelve months ending in the quarter Mar 31 2021 Jenna K. Green told.

Atyr Pharma Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
LIFE's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for LIFE's Competitors
Operating Income Growth for Atyr Pharma Inc 's Suppliers
Operating Income Growth for LIFE's Customers

You may also want to know
LIFE's Annual Growth Rates LIFE's Profitability Ratios LIFE's Asset Turnover Ratio LIFE's Dividend Growth
LIFE's Roe LIFE's Valuation Ratios LIFE's Financial Strength Ratios LIFE's Dividend Payout Ratio
LIFE's Roa LIFE's Inventory Turnover Ratio LIFE's Growth Rates LIFE's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2022
Pacific Health Care Organization Inc.117.35%$ 117.350 millions
Amphastar Pharmaceuticals Inc 109.72%$ 109.722 millions
Eli Lilly And Company108.11%$ 108.110 millions
Ethema Health Corporation 93.26%$ 93.259 millions
Harmony Biosciences Holdings inc 89.61%$ 89.610 millions
Merck and Co Inc 84.77%$ 84.771 millions
Maravai Lifesciences Holdings Inc 81.05%$ 81.050 millions
Option Care Health Inc 79.57%$ 79.573 millions
Catalyst Pharmaceuticals Inc 77.19%$ 77.186 millions
Iradimed Corp73.04%$ 73.040 millions
Viemed Healthcare Inc 68.77%$ 68.769 millions
Repligen Corp64.91%$ 64.912 millions
Alr Technologies Inc 58.99%$ 58.990 millions
Surgery Partners Inc 56.14%$ 56.143 millions
Assertio Holdings inc 53.98%$ 53.976 millions
Integra Lifesciences Holdings Corp50.30%$ 50.303 millions
Becton Dickinson And Company50.23%$ 50.230 millions
Mednax Inc 49.82%$ 49.816 millions
Iqvia Holdings Inc 44.74%$ 44.737 millions
The Pennant Group Inc 44.20%$ 44.203 millions
Abcellera Biologics Inc 42.31%$ 42.307 millions
Bio rad Laboratories Inc 42.20%$ 42.197 millions
Abbott Laboratories38.07%$ 38.075 millions
Corcept Therapeutics Inc36.31%$ 36.312 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SIER's Profile

Stock Price

SIER's Financials

Business Description

Fundamentals

Charts & Quotes

SIER's News

Suppliers

SIER's Competitors

Customers & Markets

Economic Indicators

SIER's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071